Pulmatrix, Inc. Files 2024 10-K
Ticker: PULM · Form: 10-K · Filed: Mar 21, 2025 · CIK: 1574235
Sentiment: neutral
Topics: 10-K, financials, pharmaceutical
TL;DR
Pulmatrix filed its 2024 10-K. Financials for 2024, 2023, 2022 disclosed.
AI Summary
Pulmatrix, Inc. filed its 2024 10-K on March 21, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, formerly known as Ruthigen, Inc., is based in Framingham, MA. Key financial data for the periods ending December 31, 2024, 2023, and 2022, including preferred stock, common stock, additional paid-in capital, and retained earnings, were disclosed.
Why It Matters
This filing provides investors with a comprehensive overview of Pulmatrix, Inc.'s financial health and operational performance for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Pulmatrix faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in their 10-K filings.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the 10-K)
- 2023 — Previous Fiscal Year End (Comparative financial data)
- 2022 — Prior Fiscal Year End (Comparative financial data)
Key Players & Entities
- Pulmatrix, Inc. (company) — Filer of the 10-K
- Ruthigen, Inc. (company) — Former name of Pulmatrix, Inc.
- 2024-12-31 (date) — Fiscal year end
- 2025-03-21 (date) — Filing date
- Framingham, MA (location) — Company address
FAQ
What is the primary business of Pulmatrix, Inc. as indicated by its SIC code?
Pulmatrix, Inc. is classified under the SIC code 2834, which corresponds to Pharmaceutical Preparations.
When was Pulmatrix, Inc. formerly known as Ruthigen, Inc. and when did the name change occur?
The company was formerly known as Ruthigen, Inc., and the date of the name change was April 11, 2013.
What is the business address of Pulmatrix, Inc.?
The business address of Pulmatrix, Inc. is 945 Concord Street, Suite 1217, Framingham, MA 01701.
What are the key financial statement components reported for the fiscal years ending December 31, 2024, 2023, and 2022?
The filing reports on Preferred Stock, Common Stock, Additional Paid-In Capital, and Retained Earnings for these fiscal years.
On what date was this 10-K filing submitted to the SEC?
This 10-K filing was submitted to the SEC on March 21, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 21, 2025 regarding Pulmatrix, Inc. (PULM).